Expertise in
9
conditions

Dr. John Kingrey

Pulmonary Medicine
Office
3400 NW Expressway Ste 300, 
Oklahoma City, OK 
Offers Telehealth
Expertise in
9
conditions
Office
3400 NW Expressway Ste 300, 
Oklahoma City, OK 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

John Kingrey is a Pulmonary Medicine provider in Oklahoma City, Oklahoma. Dr. Kingrey is highly rated in 9 conditions, according to our data. His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Acute Interstitial Pneumonia, Endoscopy, and Advanced Bronchoscopy.

His clinical research consists of co-authoring 7 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pulmonary Medicine
Licenses
Internal Medicine in OH
Hospital Affiliations
Integris Baptist Medical Center, Inc
Saint Francis Hospital South, LLC
Ascension St John Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Arkansas Health and Wellness
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

GlobalHealth
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Office
3400 NW Expressway Ste 300, Oklahoma City, OK 73112
Call: 405-553-0581
Other Locations
INTEGRIS Baptist Medical Center
3300 NW Expressway, Oklahoma City, OK 73112
Call: 405-949-3349

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Active_not_recruiting
Publish Date: June 24, 2025
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Completed
Publish Date: June 10, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 3
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
Enrollment Status: Active_not_recruiting
Publish Date: March 28, 2025
Intervention Type: Drug
EXPEDITE: A 16-Week, Multicenter, Open-label Study of Remodulin Induction Followed by Orenitram Optimization in Subjects With Pulmonary Arterial Hypertension
EXPEDITE: A 16-Week, Multicenter, Open-label Study of Remodulin Induction Followed by Orenitram Optimization in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: August 07, 2023
Intervention Type: Drug
Study Drug: Intravenous/Subcutaneous Treprostinil
Study Phase: Phase 4
A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous (SC) Injections of a Sustained-Release Vasoactive Intestinal Peptide (VIP) Analogue, Pemziviptadil (PB1046), in Adult Subjects With Symptomatic Pulmonary Arterial Hypertension (PAH)
A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous (SC) Injections of a Sustained-Release Vasoactive Intestinal Peptide (VIP) Analogue, Pemziviptadil (PB1046), in Adult Subjects With Symptomatic Pulmonary Arterial Hypertension (PAH)
Enrollment Status: Terminated
Publish Date: August 23, 2022
Intervention Type: Drug
Study Drug: Pemziviptadil
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) Subcutaneous Injections in Pulmonary Arterial Hypertension Subjects Following Completion of Study PB1046-PT-CL-0004
A Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) Subcutaneous Injections in Pulmonary Arterial Hypertension Subjects Following Completion of Study PB1046-PT-CL-0004
Enrollment Status: Terminated
Publish Date: February 22, 2022
Intervention Type: Drug
Study Drug: Pemziviptadil
Study Phase: Phase 2
View 8 Less Clinical Trials

7 Total Publications

Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study.
Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study.
Journal: Advances in therapy
Published: April 17, 2025
View All 7 Publications
Similar Doctors
Expertise in
38
conditions
Dr. Shoab A. Nazir
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine
Expertise in
38
conditions
Dr. Shoab A. Nazir
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine

Oklahoma Sleep Lung And Critical Care PLLC

5608 Se 67th St, Suite 106, 
Oklahoma City, OK 
 (12.1 miles away)
405-682-8383
Languages Spoken:
English, Hindi, Malayalam, Tamil, Urdu
See accepted insurances
Accepting New Patients

Shoab Nazir is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Oklahoma City, Oklahoma. Dr. Nazir is highly rated in 38 conditions, according to our data. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Pneumonia, Gastrostomy, and Endoscopy. Dr. Nazir is currently accepting new patients.

Expertise in
20
conditions
Dr. Mark S. Fixley
Pulmonary Medicine | Intensive Care Medicine
Expertise in
20
conditions
Dr. Mark S. Fixley
Pulmonary Medicine | Intensive Care Medicine
4050 W Memorial Rd Fl 3, 
Oklahoma City, OK 
 (3.5 miles away)
405-608-3800
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mark Fixley is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Oklahoma City, Oklahoma. Dr. Fixley is highly rated in 20 conditions, according to our data. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Chronic Cough, Advanced Bronchoscopy, and Endoscopy. Dr. Fixley is currently accepting new patients.

Expertise in
18
conditions
Dr. Arun K. Devakonda
Pulmonary Medicine | Intensive Care Medicine
Expertise in
18
conditions
Dr. Arun K. Devakonda
Pulmonary Medicine | Intensive Care Medicine

Integris Ambulatory Care Corporation

Oklahoma City, OK 
 (7.3 miles away)
405-636-7452
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Arun Devakonda is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Oklahoma City, Oklahoma. Dr. Devakonda is highly rated in 18 conditions, according to our data. His top areas of expertise are Emphysema, Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Advanced Bronchoscopy, and Gastrostomy. Dr. Devakonda is currently accepting new patients.

VIEW MORE Pulmonologists

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kingrey's expertise for a condition
ConditionClose
  • Elite
  • Pulmonary Hypertension
    Dr. Kingrey is
    Elite
    . Learn about Pulmonary Hypertension.
    See more Pulmonary Hypertension experts
  • Distinguished
  • Acute Interstitial Pneumonia
    Dr. Kingrey is
    Distinguished
    . Learn about Acute Interstitial Pneumonia.
    See more Acute Interstitial Pneumonia experts
  • Lung Metastases
    Dr. Kingrey is
    Distinguished
    . Learn about Lung Metastases.
    See more Lung Metastases experts
  • Pulmonary Fibrosis
    Dr. Kingrey is
    Distinguished
    . Learn about Pulmonary Fibrosis.
    See more Pulmonary Fibrosis experts
  • Pulmonary Veno-Occlusive Disease
    Dr. Kingrey is
    Distinguished
    . Learn about Pulmonary Veno-Occlusive Disease.
    See more Pulmonary Veno-Occlusive Disease experts
  • Advanced
  • Hypersensitivity Pneumonitis
    Dr. Kingrey is
    Advanced
    . Learn about Hypersensitivity Pneumonitis.
    See more Hypersensitivity Pneumonitis experts
  • Idiopathic Pulmonary Fibrosis
    Dr. Kingrey is
    Advanced
    . Learn about Idiopathic Pulmonary Fibrosis.
    See more Idiopathic Pulmonary Fibrosis experts
  • Interstitial Lung Disease
    Dr. Kingrey is
    Advanced
    . Learn about Interstitial Lung Disease.
    See more Interstitial Lung Disease experts
  • Pneumonia
    Dr. Kingrey is
    Advanced
    . Learn about Pneumonia.
    See more Pneumonia experts
  • Experienced
  • Advanced Bronchoscopy
    Dr. Kingrey is
    Experienced
    . Learn about Advanced Bronchoscopy.
    See more Advanced Bronchoscopy experts
  • Allergic Bronchopulmonary Aspergillosis
    Dr. Kingrey is
    Experienced
    . Learn about Allergic Bronchopulmonary Aspergillosis.
    See more Allergic Bronchopulmonary Aspergillosis experts
  • Atypical Pneumonia
    Dr. Kingrey is
    Experienced
    . Learn about Atypical Pneumonia.
    See more Atypical Pneumonia experts
  • Bronchiectasis
    Dr. Kingrey is
    Experienced
    . Learn about Bronchiectasis.
    See more Bronchiectasis experts
  • Bronchiolitis Obliterans
    Dr. Kingrey is
    Experienced
    . Learn about Bronchiolitis Obliterans.
    See more Bronchiolitis Obliterans experts
  • Bronchitis
    Dr. Kingrey is
    Experienced
    . Learn about Bronchitis.
    See more Bronchitis experts
View All 28 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
  1. Homepage
  2. Pulmonologists Oklahoma City, OK
  3. Dr. John Kingrey
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.